Results 1 to 10 of about 3,105,782 (329)

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya. [PDF]

PLoS ONE, 2012
BACKGROUND: In resource-limited settings where viral load (VL) monitoring is scarce or unavailable, clinicians must use immunological and clinical criteria to define HIV virological treatment failure.
Cecilia Ferreyra, Oliver Yun, Nell Eisenberg, Elena Alonso, Ashimosi S Khamadi, Matilu Mwau, Martha Kihara Mugendi, Ana Alvarez, Elena Velilla, Laurence Flevaud, Mireia Arnedo, David Dalmau, Paul Roddy, Andrea Bernasconi, Pedro Pablo Palma   +14 more
doaj   +38 more sources

High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015. [PDF]

PLoS ONE, 2017
BackgroundThe number of people living with HIV on antiretroviral treatment (ART) in Myanmar has been increasing rapidly in recent years. This study aimed to estimate rates of virological failure on first-line ART and switching to second-line ART due to ...
Nang Thu Thu Kyaw, Anthony D Harries, Ajay M V Kumar, Myo Minn Oo, Khine Wut Yee Kyaw, Than Win, Thet Ko Aung, Aung Chan Min, Htun Nyunt Oo   +8 more
doaj   +6 more sources

Incidence, survival time and associated factors of virological failure among adult HIV/AIDS patients on first line antiretroviral therapy in St. Paul's Hospital Millennium Medical College-A retrospective cohort study.

PLoS ONE, 2022
IntroductionHuman Immune deficiency Virus or Acquired Immune deficiency Syndrome (HIV/AIDS) is a pandemic affecting millions around the world. The 2020 the Joint United Nations Programme on HIV/AIDS report stated that the estimated number of people ...
Demeke Eshetu Andarge, Haimanot Ewnetu Hailu, Takele Menna   +2 more
doaj   +3 more sources

Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis

AIDS Research and Therapy, 2021
Background Progress toward the global target for 95% virological suppression among those on antiretroviral treatment (ART) is still suboptimal. We describe the viral load (VL) cascade, the incidence of virological failure and associated risk factors ...
Anita Mesic, Alexander Spina, Htay Thet Mar, Phone Thit, Tom Decroo, Annick Lenglet, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tobias Homan, Mitchell Sangma, Ronald Kremer, Jane Grieg, Erwan Piriou, Koert Ritmeijer, Josefien Van Olmen, Lutgarde Lynen, Htun Nyunt Oo   +17 more
doaj   +2 more sources

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy

Journal of the International Association of Providers of AIDS Care, 2020
Background: The implication and clinical significance of low-level viremia (LLV) in HIV patients are still not clear. This study aimed to characterize the clinical outcomes and to evaluate whether LLV could predict future virological failure in a well ...
Zied Gaifer MBBS, MD, Mohamed-Rachid Boulassel DEMS, PhD   +1 more
doaj   +2 more sources

Virological failure and associated factors among children receiving anti-retroviral therapy, Northwest Ethiopia.

PLoS ONE, 2021
BackgroundVirological failure is under-recognized issue among children living with human immunodeficiency virus in developing countries. This partly may lead to failure to achieve the global goal of 90-90-90 targets in most developing countries including
Biruk Bayleyegn, Zemene Demelash Kifle, Demeke Geremew   +2 more
doaj   +2 more sources

Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis. [PDF]

Clin Infect Dis
Background Long-acting (LA) injectable therapy with cabotegravir (CAB) and rilpivirine (RPV) is currently used as maintenance treatment for human immunodeficiency virus type 1, and has a low risk for virological failure (VF).
van Welzen BJ, Van Lelyveld SFL, Ter Beest G, Gisolf JH, Geerlings SE, Prins JM, Van Twillert G, Van Nieuwkoop C, Van der Valk M, Burger D, Wensing AMJ.   +10 more
europepmc   +2 more sources

Magnitude and associated factors of virological failure among children on ART in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study

Italian Journal of Pediatrics, 2021
Background Despite the rapid scale-up of antiretroviral therapy, virologic failure has become global public health concern and challenge, especially in developing countries. Viral load monitoring is an important approach to identify treatment failure and
Belete Gelaw, Getasew Mulatu, Getasew Tesfa, Chalie Marew, Bogale Chekole, Animut Alebel   +5 more
doaj   +2 more sources

Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: A case-control study

Frontiers in Public Health, 2022
BackgroundVirological failure remains a public health concern among patients with human immunodeficiency virus (HIV) after treatment initiation. Ethiopia is one of the countries that aims to achieve the global target of 90-90-90 that aims to achieve 90 ...
Biruk Bogale, Adane Asefa, Alemnew Destaw, Gachana Midaksa, Zufan Asaye, Mathewos Alemu Gebremichael, Asrat Arja Wolde, Ejig Yimer, Tewodros Yosef   +8 more
doaj   +2 more sources

Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study

BMC Infectious Diseases, 2020
Background Although the United Nations program on HIV/AIDS 90–90-90-targets recommends achieving 90% of viral suppression for patients on first-line antiretroviral therapy by 2020, virological failure is still high and it remains a global public health ...
Chilot Desta Agegnehu, Mehari Woldemariam Merid, Melaku Kindie Yenit   +2 more
doaj   +2 more sources